← Open Payments lookup

SHELBY CHAMBERLAIN: Open Payments

NPI 1568134161 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$756 in 34 payments from 9 companies in 2025. Trend: 2023 $116 · 2024 $198 · 2025 $756

Food & beverage: $756
CompanyPaymentsAmount
Merck Sharp & Dohme LLC12$275
PFIZER INC.6$126
AstraZeneca Pharmaceuticals LP4$86
Astellas Pharma US Inc4$85
ABBVIE INC.2$54
Eisai Inc.2$49
GlaxoSmithKline, LLC.2$46
Sumitomo Pharma America, Inc.1$19
Fennec Pharmaceuticals, Inc.1$17

Products named: LYNPARZA, TIVDAK, KEYTRUDA, Veozah, ELAHERE, Lenvima, JEMPERLI, MYFEMBREE.

Industry payments across AL — which companies pay providers there.